Rafael F. Schäfers

Augmentation index is associated with cardiovascular risk

Jens Nürnberger, Ayten Keflioglu-Scheiber, Anabelle M. Opazo Saez et al. · Journal of Hypertension · 2002 · 433 citations

TAMSULOSIN TREATMENT OF 19,365 PATIENTS WITH LOWER URINARY TRACT SYMPTOMS: DOES CO-MORBIDITY ALTER TOLERABILITY?

Martin C. Michel, LUDWIG MEHLBURGER, HANS-ULRICH BRESSEL et al. · The Journal of Urology · 1998 · 109 citations

Positive inotropic effects of the beta2-adrenoceptor agonist terbutaline in the human heart: Effects of long-term beta1-adrenoceptor antagonist treatment

Rafael F. Schäfers, Sabine Adler, A Daul et al. · Journal of the American College of Cardiology · 1994 · 58 citations

Beta2-adrenoceptor Agonist Terbutaline, Adrenal Gland, Cardiovascular Disease +9

Radioreceptor assay analysis of tamsulosin and terazosin pharmacokinetics

Katsunari Taguchi, Rafael F. Schäfers, Martin C. Michel · British Journal of Clinical Pharmacology · 1998 · 57 citations · Full text

Enhanced vasoconstriction to endothelin-1, angiotensin II and noradrenaline in carriers of the GNB3 825T allele in the skin microcirculation.

René R. Wenzel, Winfried Siffert, Heike Bruck et al. · Pharmacogenetics · 2002 · 48 citations